SRES-293-117
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S4796; text: CR S4785-4786)
Sponsored by Sheldon Whitehouse (D-RI)
What it does
This resolution designates June 26, 2021, as the "International Day against Drug Abuse and Illicit Trafficking," aligning the Senate with a date already established by the United Nations General Assembly. It expresses the Senate's support for prevention, treatment, and recovery programs; commends law enforcement efforts; encourages international cooperation against drug trafficking organizations; and calls on other UN member states to observe the day. The resolution carries no binding legal force, creates no new programs, and appropriates no funds.
Who benefits
Individuals with substance use disorders, who receive symbolic congressional recognition of the need for treatment and recovery access. Law enforcement agencies and officers working on drug trafficking, who are publicly commended. International organizations and UN member states engaged in anti-drug cooperation, who receive U.S. Senate encouragement. Advocacy groups focused on drug prevention and treatment, who gain a platform for public awareness.
Who is hurt
No group is directly or materially harmed by this resolution, as it is purely symbolic and creates no legal obligations, spending, or regulatory changes. Critics of symbolic legislation more broadly may argue it consumes limited legislative time without producing actionable policy.
Supporters argue
Supporters argue that formally aligning the Senate with the UN-established observance raises public awareness of a documented public health crisis — the CDC recorded a record 91,862 drug overdose deaths between October 2019 and October 2020, and the National Institute on Drug Abuse estimates illicit drug use costs the U.S. $193 billion annually. They contend that bipartisan recognition of the problem, reflected in the resolution's broad co-sponsorship across both parties, signals congressional commitment to treatment, prevention, and international cooperation against trafficking networks.
Opponents argue
Opponents argue that a non-binding commemorative resolution does nothing to address the structural causes of the overdose crisis — it allocates no funding for treatment programs, creates no new enforcement tools, and imposes no obligations on any government or organization. They contend that with overdose deaths at record highs, congressional time and attention would be better directed toward substantive legislation on medication-assisted treatment access, fentanyl interdiction, or mental health funding rather than symbolic declarations.